These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In-vitro cytotoxicity of L-asparaginase on rodent and human neoplastic cells. Schrek R; Dolowy WC Lancet; 1970 Oct; 2(7675):722. PubMed ID: 4195957 [No Abstract] [Full Text] [Related]
3. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine. Silagi S; Balint RF; Gauri KK Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681 [No Abstract] [Full Text] [Related]
4. [Current therapy of malignant blood diseases]. de Werra P Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422 [No Abstract] [Full Text] [Related]
5. Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II. Crowther D Br Med J; 1974 Oct; 4(5938):216-8. PubMed ID: 4529039 [No Abstract] [Full Text] [Related]
6. [L-asparaginase--first specific cytostatic]. Marquardt H Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156 [No Abstract] [Full Text] [Related]
7. An assessment of massive-dose chemotherapy of malignant disease. Bergsagel DE Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068 [No Abstract] [Full Text] [Related]
8. Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine. Higgins NP; Strauss BS Cancer Res; 1979 Feb; 39(2 Pt 1):312-20. PubMed ID: 216485 [TBL] [Abstract][Full Text] [Related]
9. Adrenal steroids in the treatment of malignant hematologic disease. Cline MJ Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834 [No Abstract] [Full Text] [Related]
10. Effect of 5-bromodeoxyuridine on mouse myeloma cells. Pettengill OS; Sorenson GD In Vitro; 1974; 10(5-6):274-80. PubMed ID: 4452560 [No Abstract] [Full Text] [Related]
11. In vitro test for sensitivity of leukemic cells to L-asparaginase. Schrek R; Dolowy WC Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205 [No Abstract] [Full Text] [Related]
12. Growth kinetics of minimal tumour masses: implications for rational chemotherapy. Pileri A; Boccadoro M; Mandelli F; Amadori S Haematologica; 1981 Oct; 66(5):545-53. PubMed ID: 6796464 [No Abstract] [Full Text] [Related]
13. Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells. Mathews CK Exp Cell Res; 1975 Apr; 92(1):39-46. PubMed ID: 124255 [No Abstract] [Full Text] [Related]
14. Effect of 5-bromodeoxyuridine on hyaluronic acid synthesis of a clonal hybrid line of mouse and chinese hamster in culture. Koyama H; Ono T J Cell Physiol; 1971 Oct; 78(2):265-71. PubMed ID: 4258000 [No Abstract] [Full Text] [Related]
15. [Personal experience on the chemotherapy of leukemias and hematosarcomas]. Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537 [No Abstract] [Full Text] [Related]
16. Isolation of thymidine-resistant cells from a thymidine-sensitive acute lymphoblastic leukemia cell line. Zielke HR Cancer Res; 1979 Sep; 39(9):3373-6. PubMed ID: 289439 [TBL] [Abstract][Full Text] [Related]
17. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs]. Bollag W Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076 [No Abstract] [Full Text] [Related]
18. Cytocidal effect of dimethyl sulfoxide on normal and leukemic lymphocytes. Schrek R; Elrod LM; Batra KV Ann N Y Acad Sci; 1967 Mar; 141(1):202-13. PubMed ID: 5342257 [No Abstract] [Full Text] [Related]
19. Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects. Brusamolino E; Pagnucco G; Bernasconi C Haematologica; 1986; 71(1):60-83. PubMed ID: 3084360 [No Abstract] [Full Text] [Related]
20. Acute leukemia as a complication of cytotoxic chemotherapy. Rosner F; Grünwald HW; Zarrabi MH Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1705-7. PubMed ID: 536280 [No Abstract] [Full Text] [Related] [Next] [New Search]